of an AT after the index CB-PVI procedure were enrolled in this study. AT recurrence was defined as documented AT lasting longer than 30 s on 12-lead ECG or 24-h Holter ECG examination after a 3-month blanking period. Exclusion criteria included severe valvular disease, severe coronary artery disease, a left atrial diameter >55 mm, and the existence of a thrombus in the left atrium (LA).Written informed consent was given by all patients prior to the ablation procedure. This study protocol was approved by the institutional review board and conformed to the ethical guidelines of the 1975 Declaration of Helsinki.
Procedural ManagementCardiac computed tomography (CT) and transesophageal echocardiography (TEE) were performed the day before the ablation procedure to analyze the anatomy of the LA and PV and to rule out any intracardiac thrombi. Patients underwent conscious sedation with propofol combined with dexmedetomidine hydrochloride during the index and re-do ablation procedures. CB ablation was performed as previously described. 4 Briefly, a 14Fr deflectable sheath (FlexCath, Medtronic, Minneapolis, MN, USA) was introduced into the LA after a single transseptal puncture P ulmonary vein isolation (PVI) is a widely accepted procedure for catheter ablation in patients with atrial fibrillation (AF). 1 The major cause of atrial tachyarrhythmias (ATs) after PVI is considered to be associated with PV reconnections. 2 PVI using the secondgeneration cryoballoon (CB) is regarded as highly effective for treating AF. 3 The durability of PVI after secondgeneration CB-based PVI (CB-PVI) may significantly contribute to the clinical outcome, but details of the results after CB-PVI have not been fully investigated. The aim of this study was to assess the clinical effect of CB-PVI during the index procedure on late PV reconnections examined during re-do procedures, and to find a predictor of the maintenance of PVI status after CB-PVI.
Methods
Inclusion and Exclusion CriteriaFrom July 2014 to March 2016, CB-PVI was performed in patients with drug-refractory AF. After the index CB-PVI procedure, re-do ablation procedures were performed in patients with drug-refractory recurrence of ATs. Consecutive patients undergoing a re-do procedure for a recurrence
Predictors of a Persistent Status of Pulmonary Vein Electrical Isolation by a Cryoballoon Application for Drug-Refractory Atrial FibrillationNaohiko Kawaguchi, MD; Kaoru Okishige, MD; Yasuteru Yamauchi, MD; Manabu Kurabayashi, MD; Kenzo Hirao, MD Background: Pulmonary vein isolation (PVI) using a cryoballoon (CB) is utilized for treating atrial fibrillation. This study aimed to assess the effect of the procedural characteristics of CB-based PVI (CB-PVI) on late PV reconnections.
Methods and Results:A total of 389 consecutive patients underwent the CB-PVI as their index procedure; 45 consecutive patients underwent re-do procedures (184±87 days after the index CB-PVI). A total of 146 of 178 PVs (82%) remained isolated. The occlusion grade was evaluated in 171 PVs. Complete PV occlusio...